Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. protein expression
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Protein Expression Articles & Analysis

76 news found

Creative BioMart Enhances Epitope Mapping Services to Support Antibody and Vaccine Development

Creative BioMart Enhances Epitope Mapping Services to Support Antibody and Vaccine Development

Creative BioMart, a biotechnology company focused on protein-related research solutions, has recently upgraded its epitope mapping service to better support researchers in therapeutic antibody development, vaccine design, and immunogenicity studies. ...

ByCreative BioMart


Creative BioMart Decides to Offer Special Discounts for Selected Products Each Month

Creative BioMart Decides to Offer Special Discounts for Selected Products Each Month

Creative BioMart, a leading global supplier of recombinant proteins and related research products, is excited to announce the launch of Its Monthly Special Release, a new program offering exclusive discounts of up to 50% off on a curated selection of products each month. With over 100,000 recombinant protein products in stock and a commitment to continuously ...

ByCreative BioMart


Amerigo Scientific Enhances Cell Culture Results by Introducing 3D Cell Culture Systems

Amerigo Scientific Enhances Cell Culture Results by Introducing 3D Cell Culture Systems

To date, 3D cell culture systems, including scaffold-based and scaffold-free, have been widely applied in differentiation studies, drug discovery, cancer research, gene and protein expression studies, and cellular physiological studies. Amerigo Scientific is committed to offering the latest advancements in laboratory technology to its customers. ...

ByAmerigo Scientific


ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture

ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture

As CHO (Chinese Hamster Ovary) and HEK (Human Embryonic Kidney) cells are the most well-suited mammalian cell lines for recombinant protein production and biological research, this partnership represents a significant milestone in advancing biopharmaceutical development by providing ExcellGene’s pioneering transposon technologies to Cytovance’s biopharma customers. ...

ByExcellGene SA


Amerigo Scientific Highlights Cell-Free Expression Supplies with pEU Vector Set

Amerigo Scientific Highlights Cell-Free Expression Supplies with pEU Vector Set

Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is proud to showcase its featured offering in cell-free protein expression supplies - the pEU vector set. This innovative vector set allows for efficient and reliable protein expression in a cell-free ...

ByAmerigo Scientific


Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

This enzyme plays a fundamental role in various biological processes including gene expression, protein function, and metabolic activity. Thus, having a quality and reliable source of SAHH is vital for research institutions and industries to advance their understanding and application of this pivotal enzyme. ...

ByCreative Enzymes


BOC Sciences Celebrates Nobel Prize Awarded to Scientists Behind COVID-19 Vaccines

BOC Sciences Celebrates Nobel Prize Awarded to Scientists Behind COVID-19 Vaccines

BOC Sciences expressed its congratulations to Katalin Karikó and Drew Weissman for being recipients of the 2023 Nobel Prize in Physiology or Medicine. ...

ByBOC Sciences


Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells

Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells

Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical products and alternative proteins for human and animal health. Dyadic’s gene ...

ByDyadic International, Inc.


Multi-protein Expression Service in Insect Cells Now Available at Profacgen

Multi-protein Expression Service in Insect Cells Now Available at Profacgen

Profacgen, one of the leading biotechnology companies that provides first-class protein expression services, recently announced the release of multi-protein expression service in insect cells, to help scientists conduct protein co-expression network analysis and interaction studies. ...

ByProfacgen


CD BioGlyco Announced Service for Analysis of Glycolytic Enzymes in Cancer Cells

CD BioGlyco Announced Service for Analysis of Glycolytic Enzymes in Cancer Cells

Increasing the activity of glycolytic enzymes and overexpressing them are the primary methods for enhancing glycolysis in cancer cells. As a result, the expression, activity, and interactions of enzymes at various points along the glycolytic pathway are primarily examined in proteomic analysis of cancer cell glycolysis. Antitumor therapy now focuses on targeting enzymes that are ...

ByCD BioGlyco.


CD Bioparticles Launches mRNA Transfection Reagents for Research Applications

CD Bioparticles Launches mRNA Transfection Reagents for Research Applications

Of course, mRNA transfection is limited to instantaneous expressions. Unlike DNA and viral vectors, mRNA will not be inserted into the host genomes that modify genetic information, and proteins encoded by mRNA fragments will only be expressed instantaneously and then degraded rapidly, minimizing the risk of gene integration and being highly safe. ...

ByCD Bioparticles


Revolutionizing Biopharma manufacturing

Revolutionizing Biopharma manufacturing

LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients. Revolutionizing Biopharma manufacturing LenioBio develops efficient and sustainable technologies for protein expression. ...

ByLenioBio GmbH


MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024

MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024

About Pelabresib Pelabresib (CPI-0610) is an investigational selective small molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. ...

ByMorphoSys AG


MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022

About Pelabresib Pelabresib (CPI-0610) is an investigational selective small molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. ...

ByMorphoSys AG


Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria

Lumen Bioscience Announces Publication in NPJ Vaccines of Preclinical Data Demonstrating Needle Free, Spirulina-produced Vaccination Offering Protection Against Malaria

Lumen Bioscience pioneered genetic engineering methods to highly express bioactive proteins in spirulina. The published research details how this platform was used to express a malaria protein antigen that can be delivered intranasally and later boosted with a simple oral booster. ...

ByLumen Bioscience, Inc.


iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update

iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update

Vaccines As previously reported, preclinical studies of IBIO-202, the Company’s vaccine candidate that uses a nucleocapsid (“N”) antigen rather than the more mutable spike (“S”) protein of SARS-CoV-2, demonstrated a robust, antigen-specific, memory T-cell response. ...

ByIbio, Inc.


iBio acquires multiple assets of Al drug discovery partner RubrYc

iBio acquires multiple assets of Al drug discovery partner RubrYc

"This was clearly demonstrated with iBio's pipeline Target 6, a mutated form of a protein expressed in a number of tumors." RubrYc's Discovery Engine enabled the rapid identification of antibodies that selectively bind the mutated protein, without binding the wild-type version, which is more commonly expressed in healthy ...

ByIbio, Inc.


iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

“This was clearly demonstrated with iBio’s pipeline Target 6, a mutated form of a protein expressed in a number of tumors. RubrYc’s Discovery Engine enabled the rapid identification of antibodies that selectively bind the mutated protein, without binding the wild-type version, which is more commonly expressed in ...

ByIbio, Inc.


SilcsBio and Helix BioStructures Launch Partnership to Collaborate in Fueling Pharmaceutical Drug Design Opportunities

SilcsBio and Helix BioStructures Launch Partnership to Collaborate in Fueling Pharmaceutical Drug Design Opportunities

“With the skill sets of both our teams, this partnership provides our customers with a unique, specialized offering comprising SilcsBio’s structure-based drug design software and our 3D protein (crystal) structures.” About Helix BioStructures: Helix is a privately held company based in Indianapolis, IN providing protein design and ...

BySilcsBio, LLC


CD BioGlyco Provides Integrated Solutions for Glycoprotein Vaccine Design

CD BioGlyco Provides Integrated Solutions for Glycoprotein Vaccine Design

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are critical in viral attachment and cell fusion, and investigation of these proteins may provide valuable insights into their potential use in vaccines and antiviral strategies. ...

ByCD BioGlyco.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT